Intravenous Thrombolysis in a Patient with Known Cavernous Malformation: A First Case Report
Am J Emerg Med 28:117.e1-117.e3, Henninger, N.,et al, 2010
Basilar Occlusion Syndromes: An Update
Neurohosp 5:142-150, Demel, S.L. & Broderick, J.P., 2015
Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005
Intravenous r-TPA in Vertebrobasilar Acute Infarcts
Neurol 62:1854-1856, Montavont,A.,et al, 2004
Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke
AJNR 24:1827-1833, Lin,D.D.M.,et al, 2003
Early Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Arch Neurol 55:466-469, 4501998., Grond,M.,et al, 1998
Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987